| 13.91 -0.16 (-1.14%) | 02-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 16.76 | 1-year : | 19.57 |
| Resists | First : | 14.35 | Second : | 16.76 |
| Pivot price | 13.85  |
|||
| Supports | First : | 13.38 | Second : | 12.78 |
| MAs | MA(5) : | 13.86  |
MA(20) : | 13.79 |
| MA(100) : | 11.95 |
MA(250) : | 11.06 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 60.2 |
D(3) : | 52.6 |
| RSI | RSI(14): 56.2 |
|||
| 52-week | High : | 14.35 | Low : | 10.22 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PCSC ] has closed below upper band by 42.7%. Bollinger Bands are 16.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 14.3 - 14.37 | 14.37 - 14.44 |
| Low: | 13.72 - 13.81 | 13.81 - 13.88 |
| Close: | 13.77 - 13.91 | 13.91 - 14.04 |
Perceptive Capital Solutions Corp does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities operating in the life sciences and medical technology sectors in North America or Europe. Perceptive Capital Solutions Corp was incorporated in 2024 and is based in New York, New York.
Fri, 05 Dec 2025
Freenome in SPAC Merger with Perceptive Capital Solutions - Medical Device and Diagnostic industry
Wed, 12 Jun 2024
PCSC IPO News - Perceptive Advisors' SPAC Perceptive Capital Solutions prices $75 million IPO - renaissancecapital.com
Wed, 12 Jun 2024
Perceptive Capital Solutions Corp Prices of $75 Million IPO - citybiz
Tue, 21 May 2024
PCSC IPO News - Perceptive Advisors' SPAC Perceptive Capital Solutions files for a $75 million IPO - renaissancecapital.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Shell Companies
|
|
| Shares Out | 9 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 3.2 (%) |
| Held by Institutions | 111.6 (%) |
| Shares Short | 747 (K) |
| Shares Short P.Month | 282 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.29 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -85.4 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | -49.68 |
| Price to Sales | 0 |
| Price to Cash Flow | -165.38 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|